Trastuzumab emtansine, Kadcyla manufactured by Roche, was appraised by NICE as a treatment option for people with HER2+ advanced breast cancer that...

8 August 2014

Responding to today’s decision (Friday 8 August 2014) by the National Institute for Health and Care Excellence (NICE) not to recommend NHS access...

8 August 2014

Breast Cancer Campaign comments on research released today in the New England Journal of Medicine about the connection between mutations in the gene...

7 August 2014

The research published in the journal Cancer Research today aimed to identify whether different types of oral contraceptives increase risk by...

1 August 2014

The four year project will allow scientists to do pioneering new research to decode 100,000 human genomes – a patient’s personal DNA code, which...

1 August 2014

On Friday August 1st 2014 Rachel Rawson Clinical Nurse Specialist at Breast Cancer Care comments on the study published in Cancer Research a...

1 August 2014

The latest annual National Statistics on waiting times for suspected and diagnosed cancer patients accessing NHS services, produced by NHS England,...

25 July 2014

Commenting on draft guidance from the National Institute for Health and Care Excellence (NICE) published today (Friday 25 July 2014) on the use of...

25 July 2014

The research will be presented today at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. The meeting is organised by the Council...

4 July 2014